NeuroSonic
Instant stroke-risk assessment for clinicians.
NeuroSonic enables clinicians to instantly assess blood flow in arteries supplying the brain, a crucial indicator of stroke risk. Its personalized insights empower care teams to detect risk factors earlier and tailor interventions.
Founders
Mike Ryan
CEO
Mike is a biomedical engineer, who filed his first patent for a medical device at 18. He is an ex-CERN researcher and Dyson award winner.
Matthew Campbell
CTO
Matthew is a biomedical engineer specializing in arterial biomechanics. He’s researched neurodegenerative disease and cofounded the Formula Trinity EV team.